These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16914600

  • 1. Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition.
    Hero M, Ankarberg-Lindgren C, Taskinen MR, Dunkel L.
    Eur J Endocrinol; 2006 Sep; 155(3):453-60. PubMed ID: 16914600
    [Abstract] [Full Text] [Related]

  • 2. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
    Wickman S, Saukkonen T, Dunkel L.
    Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
    [Abstract] [Full Text] [Related]

  • 3. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 4. Cognitive effects of aromatase inhibitor therapy in peripubertal boys.
    Hero M, Maury S, Luotoniemi E, Service E, Dunkel L.
    Eur J Endocrinol; 2010 Jul; 163(1):149-55. PubMed ID: 20421333
    [Abstract] [Full Text] [Related]

  • 5. Estrogen suppression in males: metabolic effects.
    Mauras N, O'Brien KO, Klein KO, Hayes V.
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2370-7. PubMed ID: 10902781
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M, Norjavaara E, Dunkel L.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A.
    Horm Res Paediatr; 2010 Dec; 74(6):428-35. PubMed ID: 20628237
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel treatment of short stature with aromatase inhibitors.
    Dunkel L, Wickman S.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
    [Abstract] [Full Text] [Related]

  • 10. Low serum adiponectin levels are associated with reduced insulin sensitivity and lipid disturbances in short children born small for gestational age.
    Huang Y, Li Y, Chen Q, Chen H, Ma H, Su Z, Du M.
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):78-84. PubMed ID: 25382353
    [Abstract] [Full Text] [Related]

  • 11. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK, Kumar RB, Payne SL, Ranadive SA, Suchet DI.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [Abstract] [Full Text] [Related]

  • 12. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
    Roemmich JN, Clark PA, Lusk M, Friel A, Weltman A, Epstein LH, Rogol AD.
    Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
    [Abstract] [Full Text] [Related]

  • 13. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.
    Baratta R, Amato S, Degano C, Farina MG, Patanè G, Vigneri R, Frittitta L.
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2665-71. PubMed ID: 15181039
    [Abstract] [Full Text] [Related]

  • 14. Sex hormones and the changes in adolescent male lipids: longitudinal studies in a biracial cohort.
    Morrison JA, Barton BA, Biro FM, Sprecher DL.
    J Pediatr; 2003 Jun; 142(6):637-42. PubMed ID: 12838191
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M, Wickman S, Dunkel L.
    Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.
    Singh AB, Hsia S, Alaupovic P, Sinha-Hikim I, Woodhouse L, Buchanan TA, Shen R, Bross R, Berman N, Bhasin S.
    J Clin Endocrinol Metab; 2002 Jan; 87(1):136-43. PubMed ID: 11788637
    [Abstract] [Full Text] [Related]

  • 20. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
    Macut D, Damjanovic S, Panidis D, Spanos N, Glisic B, Petakov M, Rousso D, Kourtis A, Bjekic J, Milic N.
    Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.